Literature DB >> 16793492

Resource consumption and costs of palliative care services in Spain: a multicenter prospective study.

Xavier Gómez-Batiste1, Albert Tuca, Esther Corrales, Josep Porta-Sales, Maria Amor, José Espinosa, Josep M A Borràs, Isabel de la Mata, Xavier Castellsagué.   

Abstract

Patients (n=395) with terminal-stage cancer receiving attention from palliative care services (PCSs) were recruited over a period of 15 consecutive days from 171 participating PCS units. Resource consumption and costs were evaluated for 16 weeks of follow-up, and the findings were compared with a study conducted in 1992 so as to assess change over time. The most frequent health care interventions were homecare visits, hospital admissions, and patient-consultant phone calls. PCS provided 67% of all services and consultation interventions in 91% of patients. Compared with the historical data, there was a significant shift from the use of conventional hospital beds toward palliative care beds, a reduced hospital stay (25.5-19.2 days; P=0.002), an increase in the death-at-home option (31%-42%), a lower use of hospital emergency rooms (52%-30.6%; P=0.001), and an increase in programmed care. Compared to the previous resource consumption and expenditure study in 1992, the current PCS policy implies a cost saving of 61%, with greater efficiency and no compromise of patient care.

Entities:  

Mesh:

Year:  2006        PMID: 16793492     DOI: 10.1016/j.jpainsymman.2005.11.015

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  21 in total

1.  Terminal patients in Belgian nursing homes: a cost analysis.

Authors:  Steven Simoens; Betty Kutten; Emmanuel Keirse; Paul Vanden Berghe; Claire Beguin; Marianne Desmedt; Myriam Deveugele; Christian Léonard; Dominique Paulus; Johan Menten
Journal:  Eur J Health Econ       Date:  2012-02-26

2.  Chemotherapy at the end of life: up until when?

Authors:  Jaime Sanz Ortiz
Journal:  Clin Transl Oncol       Date:  2012-07-07       Impact factor: 3.405

3.  Can this patient be discharged home? Factors associated with at-home death among patients with cancer.

Authors:  Alberto Alonso-Babarro; Eduardo Bruera; María Varela-Cerdeira; María Jesús Boya-Cristia; Rosario Madero; Isabel Torres-Vigil; Javier De Castro; Manuel González-Barón
Journal:  J Clin Oncol       Date:  2011-02-22       Impact factor: 44.544

Review 4.  Economic impact of hospital inpatient palliative care consultation: review of current evidence and directions for future research.

Authors:  Peter May; Charles Normand; R Sean Morrison
Journal:  J Palliat Med       Date:  2014-07-01       Impact factor: 2.947

5.  Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population.

Authors:  Yumi Asukai; Amparo Valladares; Carlos Camps; Eifiona Wood; Kaisa Taipale; Jorge Arellano; Alejo Cassinello; José Antonio Sacristán; Tatiana Dilla
Journal:  BMC Cancer       Date:  2010-01-29       Impact factor: 4.430

6.  The impact of hospice care on survival and cost saving among patients with liver cancer: a national longitudinal population-based study in Taiwan.

Authors:  Jui-Kun Chiang; Yee-Hsin Kao
Journal:  Support Care Cancer       Date:  2014-10-04       Impact factor: 3.603

7.  The Ambulatory and Home Care Record: A Methodological Framework for Economic Analyses in End-of-Life Care.

Authors:  Denise N Guerriere; Peter C Coyte
Journal:  J Aging Res       Date:  2011-05-19

Review 8.  Elements of effective palliative care models: a rapid review.

Authors:  Tim Luckett; Jane Phillips; Meera Agar; Claudia Virdun; Anna Green; Patricia M Davidson
Journal:  BMC Health Serv Res       Date:  2014-03-26       Impact factor: 2.655

9.  Impact of a home-based social welfare program on care for palliative patients in the Basque Country (SAIATU Program).

Authors:  Emilio Herrera Molina; Roberto Nuño-Solinis; Gorka Espiau Idioaga; Silvia Librada Flores; Naomi Hasson; Juan F Orueta Medía
Journal:  BMC Palliat Care       Date:  2013-01-30       Impact factor: 3.234

10.  Cost effectiveness of first-line treatment with doxorubicin/ifosfamide compared to trabectedin monotherapy in the management of advanced soft tissue sarcoma in Italy, Spain, and sweden.

Authors:  Julian F Guest; Monica Panca; Erikas Sladkevicius; Nicholas Gough; Mark Linch
Journal:  Sarcoma       Date:  2013-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.